PD-1+ T cells were mainly CD4+, with 77.0 ± 7.5% in PBMC HC not significantly more frequent than in PBMC HNSCC (68.0 ± 12.2%). The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.